Meeting ReportBasic and Translational Neurosciences
Preclinical development of GluN2B-containing NMDA receptors imaging probes in rodents and their prospective use in multiple sclerosis patients
Hazem Ahmed, Ahmed Haider, Rahel Wallimann, Stefan Gruber, Livio Gisler, Claudia Keller, Roger Schibli, Benhard Wünsch, Linjing Mu, Steven Liang and Simon Ametamey
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2314;
Hazem Ahmed
1ETH Zurich
Ahmed Haider
2Harvard Medical School
Rahel Wallimann
1ETH Zurich
Stefan Gruber
1ETH Zurich
Livio Gisler
1ETH Zurich
Claudia Keller
1ETH Zurich
Roger Schibli
1ETH Zurich
Benhard Wünsch
3Institute of Pharmaceutical and Medicinal Chemistry, University of Münster
Linjing Mu
1ETH Zurich
Steven Liang
4Harvard Medical School and Mass General Hospital
Simon Ametamey
1ETH Zurich

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
Preclinical development of GluN2B-containing NMDA receptors imaging probes in rodents and their prospective use in multiple sclerosis patients
Hazem Ahmed, Ahmed Haider, Rahel Wallimann, Stefan Gruber, Livio Gisler, Claudia Keller, Roger Schibli, Benhard Wünsch, Linjing Mu, Steven Liang, Simon Ametamey
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2314;
Preclinical development of GluN2B-containing NMDA receptors imaging probes in rodents and their prospective use in multiple sclerosis patients
Hazem Ahmed, Ahmed Haider, Rahel Wallimann, Stefan Gruber, Livio Gisler, Claudia Keller, Roger Schibli, Benhard Wünsch, Linjing Mu, Steven Liang, Simon Ametamey
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2314;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.